Dolutegravir Use and Predictors of CNS events: Meta-analysis of Data from Phase III/IIIb Clinical Trials

First published 05/12/2018

Last updated 02/04/2024

EU PAS number:

EUPAS26866

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

viiv-207953-protocol-redact

English (389.59 KB - PDF)View document

Study results

Study results

viiv-207953-clinical-study-report-redact

English (2.46 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents